Long Non-Coding RNA MAFG-AS1 Regulates the Proliferation and Epithelial to Mesenchymal Transition of Human Esophageal Carcinoma Cells

Shuhong Kang,Haihua Guo,Ke Lan,Ning Guo,ShiPeng Lu,Feng Lv,Yunfeng Ni
DOI: https://doi.org/10.3923/ijp.2024.552.560
2024-01-01
International Journal of Pharmacology
Abstract:Background and Objective: Esophageal carcinoma (EC) is considered a major type of neoplastic disorder of the human gastrointestinal tract and causes significant mortality and morbidity across the globe. This research was done to find out if the Long Non-coding RNA (lncRNA) MAFG-AS1 affects the growth of human esophageal carcinoma (HEC) cells and their change from an epithelial to a mesenchymal state. Materials and Methods: The 44 pairs of tissue specimens were taken from carcinoma patients between the ages of 38 and 73. The HEC cell lines (EC109, TE-10 and KYSE-410) together with Het-1A and human esophageal epithelial cells, were utilized in this study. Transient transfection, RNA isolation, cDNA synthesis, RT-PCR analysis, MTT proliferation and clonogenic assays, EdU incorporation assays and the transwell assay were performed by standard methods. Results: The outcomes of this investigation showed that EC samples and cell lines exhibit considerable (p<0.05) expression of MAFG-AS1. The MAFG-AS1 knockdown substantially (p<0.05) decreased the growth of EC109 and KYSE-410 esophageal cancer cells via apoptosis, a rise in Bax and a reduction in Bcl-2 in EC109 and KYSE-410 esophageal cancer cells. Furthermore, in EC109 and KYSE-410, ES knockdown enhanced E-cadherin and alpha-catenin expression while reducing fibronectin and vimentin expression. Conclusion: The MAFG-AS1 can be used as a therapeutic target because it may control how HEC cells grow and change from being epithelial to mesenchymal transition (EMT) cells.
What problem does this paper attempt to address?